PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-962.12%
Both yoy net incomes decline, with VET at -97.83%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
3.33%
Some D&A expansion while VET is negative at -22.38%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-813.33%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
94.64%
SBC growth well above VET's 3.52%. Michael Burry would flag major dilution risk vs. competitor’s approach.
95.74%
Slight usage while VET is negative at -290.60%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
100.00%
AR growth of 100.00% while VET is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
95.74%
Some yoy usage while VET is negative at -290.60%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
214.46%
Well above VET's 321.40%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
84.67%
Some CFO growth while VET is negative at -90.12%. John Neff would note a short-term liquidity lead over the competitor.
14.12%
Some CapEx rise while VET is negative at -3.84%. John Neff would see competitor possibly building capacity while we hold back expansions.
113.94%
Acquisition spending well above VET's 100.00%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-14.12%
Negative yoy purchasing while VET stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-40.95%
We reduce yoy sales while VET is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
13.68%
Less 'other investing' outflow yoy vs. VET's 143.94%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
104.06%
Investing outflow well above VET's 17.05%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
94.52%
We repay more while VET is negative at -1901.47%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.